Journal list Promote Sponsor
verified SJR 11,398 · Q1 • database Scopus / SJR & Web of Science indexed
The Lancet Gastroenterology and Hepatology
United Kingdom · Elsevier Ltd
workspace_premium Q1 — Gastroenterology lock Subscription

The Lancet Gastroenterology and Hepatology

The Lancet Gastroenterology and Hepatology is a journal indexed in SJR in Gastroenterology and Hepatology with an H index of 123. It has an SJR impact factor of 11,398 and it has a best quartile of Q1. It has an SJR impact factor of 11,398.

The Lancet Gastroenterology and Hepatology focuses its scope in these topics and keywords: gastrointestinal, hepatitis, multicentre, bowel, chronic, activity, exploration, magnetic, relapsed, cessation, ...

ISSN: 2468-1253
Publisher: Elsevier Ltd
Category: Gastroenterology
Indexation: verifiedScopus / SJR verifiedWeb of Science
open_in_new Portal NPD menu_book Guidelines NPD
schedule CountryOfPapers database fields
SJR Impact Factor trending_up
11,398 Q1
H-index 123
Acceptance rate pie_chart
28% Selective
Source Acceptance_Rate
Time to publication hourglass_top
NPD
Field NPD
Publication cost (APC) payments
NPD Subscription
Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

11,398

H-index

123

Docs (year)

242

Docs 3y

682

Total refs

5228

Cites 3y

8156

Citable 3y

245

Cites/Doc 2y

13.01

Ref/Doc

21.6

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Can artificial intelligence standardise colonoscopy quality?

View more

Watch-and-wait strategy in rectal cancer -Authors' reply

View more

Direct-acting antivirals for chronic hepatitis C virus genotype 5 and 6 infections

View more

Diagnostic accuracy of MRE and ultrasound for Crohn's disease -Authors' reply

View more

Diagnostic accuracy of MRE and ultrasound for Crohn's disease

View more

Detection of colorectal adenomas with a real-time computer-aided system (ENDOANGEL): a randomised controlled study

View more

Deep learning for colorectal polyp detection: time for clinical implementation?

View more

Decision making for liver biopsy in NASH, not so FAST?

View more

Cytosponge use in risk stratification of Barrett's oesophagus

View more

Colon cancer in Asian patients with ulcerative colitis

View more

Civil society's critical role in the elimination of viral hepatitis

View more

Chronic hepatitis C: less of a problem than first thought?

View more
SHOW MORE ARTICLES

Cartoons for paediatric patients

View more

15th European Crohn's and Colitis Organisation Congress

View more

Bursectomy versus omentectomy alone for resectable gastric cancer (JCOG1001): a phase 3, open-label, randomised controlled trial

View more

Bowel cancer diagnostic services in the UK: at full capacity?

View more

Bodily Functions and Where to Find Them: comedy with a serious message

View more

Beyond the Milan criteria for liver transplantation in children with hepatic tumours

View more

Assessment of small bowel mucosal healing by video capsule endoscopy for the prediction of short-term and long-term risk of Crohn's disease flare: a prospective cohort study

View more

ASCO 2020 Gastrointestinal Cancers Symposium

View more

Apps: solutions to sociological and health problems

View more

Anti-TNF treatment failure: drug levels, immunogenicity, or both?

View more

Accelerating the elimination of viral hepatitis for Indigenous peoples

View more

A watershed moment in tackling childhood obesity

View more

FAQs